Cargando…

Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion

Bevacizumab is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the management of macular edema in central retinal vein occlusion (CRVO). Studying retinal protein changes in bevacizumab intervention may provide insights into mechanisms of action. In nine Danish Landrace pi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cehofski, Lasse Jørgensen, Kruse, Anders, Mæng, Mads Odgaard, Kjaergaard, Benedict, Grauslund, Jakob, Honoré, Bent, Vorum, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672637/ https://www.ncbi.nlm.nih.gov/pubmed/38003895 http://dx.doi.org/10.3390/jpm13111580

Ejemplares similares

Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach
por: Mæng, Mads Odgaard, et al.
Publicado: (2023)

Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics
por: Jørgensen Cehofski, Lasse, et al.
Publicado: (2015)

A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2017)

Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2020)

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

Animal Models Used to Simulate Retinal Artery Occlusion: A Comprehensive Review
por: Vestergaard, Nanna, et al.
Publicado: (2019)

Large-Scale Protein Analysis of Experimental Retinal Artery Occlusion
por: Vestergaard, Nanna, et al.
Publicado: (2023)

Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2021)

Comorbidity in patients with branch retinal vein occlusion: case-control study
por: Bertelsen, Mette, et al.
Publicado: (2012)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
por: Braimah, Imoro Z, et al.
Publicado: (2019)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Meibomian Gland Dysfunction Is Associated with Low Levels of Immunoglobulin Chains and Cystatin-SN
por: Muttuvelu, Danson Vasanthan, et al.
Publicado: (2023)

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
por: Abegg, Mathias, et al.
Publicado: (2008)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
por: Deka, Satyen, et al.
Publicado: (2009)

Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
por: Ali, Rasha I, et al.
Publicado: (2014)

The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries
por: Wu, Annie M., et al.
Publicado: (2018)

Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
por: Hall, Leangelo, et al.
Publicado: (2019)

Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study
por: Frederiksen, Katrine Hartmund, et al.
Publicado: (2023)

Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits
por: Mandal, Nakul, et al.
Publicado: (2015)

Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
por: Nagpal, Manish, et al.
Publicado: (2011)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
por: Son, Bo Kwon, et al.
Publicado: (2017)

Bevacizumab and Triamcinolone for Branch Vein Occlusion
por: Wong, Ian Yat Hin
Publicado: (2010)

Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion
por: Moon, Su Young, et al.
Publicado: (2018)

Attempting to distinguish between endogenous and contaminating cytokeratins in a corneal proteomic study
por: Lyngholm, Mikkel, et al.
Publicado: (2011)

Progression of Impending Central Retinal Vein Occlusion to the Ischemic Variant Following Intravitreal Bevacizumab
por: Kim, Na Rae, et al.
Publicado: (2010)

Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results
por: Manayath, George J, et al.
Publicado: (2009)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)

COMBINED TREATMENT WITH BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE FOR MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION
por: Vinković, Maja, et al.
Publicado: (2020)

Ocular Proteomics with Emphasis on Two-Dimensional Gel Electrophoresis and Mass Spectrometry
por: Mandal, Nakul, et al.
Publicado: (2009)

Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009)

Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis – a proteomic study
por: Vorum, Henrik, et al.
Publicado: (2007)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir, Mehmet, et al.
Publicado: (2011)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
por: Ogino, Ken, et al.
Publicado: (2011)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012)

Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Kim, Jin Young, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nvsdl82repamgli4sf264c7jib